Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 25, 2014

Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al

Track this case

Case Number:

1:14-cv-00984

Court:

Delaware

Nature of Suit:

Patent

Judge:

Richard G. Andrews

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 03, 2017

    Impax, AstraZeneca Get Win In Generic Zomig Patent Case

    A Delaware federal judge has given a victory to Impax Laboratories Inc. and AstraZeneca AB in their patent infringement suit over Lannett Holdings Inc.'s planned generic version of the migraine medication Zomig, upholding the validity of two patents Lannett conceded it infringed.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login